IMMUNOLOGY OBP

Häftad, Engelska, 2027

315 kr

Kommande

Beskrivning

Written primarily for mid-to-upper level undergraduates, this title provides an introduction to immunology with a focus on human health and disease.Immunology is written to act as a map for students to go on and explore, with enthusiasm, a fast-moving field. It gives insights into the molecular pathways and mechanisms that underlie the function of our immune systems in health and disease, the understanding of which supports the development of new therapeutics. Key Features· Oxford Biology Primers are the only resource to introduce prospective and current students of undergraduate-level bioscience to a range of topics from this dynamic experimental science, enticing readers to study further. · Its titles directly support two key transitions in the student journey: from school to undergraduate-level study, and from undergraduate to independent researcher. · Its modular format offers a high degree of flexibility, with teachers being able to draw on specific volumes that augment the post-16 curriculum and university lecturers being able to draw on specific volumes at different stages of the undergraduate curriculum.All titles in the series are available for students and institutions to purchase in a variety of formats: the e-book and Science Trove offer a mobile experience and convenient access along with functionality tools, navigation features, and links that offer extra learning support. For more information about e-books, please visit www.oxfordtextbooks.co.uk/ebooks

Produktinformation

Utgivningsdatum:2027-01-28
Mått:189 x 246 x undefined mm
Format:Häftad
Språk:Engelska
Serie:Oxford Biology Primers
Antal sidor:144
Förlag:OUP OXFORD
ISBN:9780197946213

Utforska kategorier

Människans biologi inom Naturvetenskap och teknik

Mer om författaren

Philippa Matthews is a clinician scientist and group leader at the Francis Crick Institute, London. Her research focuses on hepatitis B virus (HBV) infection, particularly molecular drivers of disease and treatment outcomes in African populations. She has held clinical and academic posts in Oxford and London, with research programmes supported by the MRC, NIHR and Wellcome Trust, and longstanding collaborations in South Africa and Uganda.Paul Klenerman is Truelove Professor of Medicine at the University of Oxford and an infectious diseases physician. His research explores T cell responses to persistent viral infections, including hepatitis C virus and cytomegalovirus, as well as unconventional T cells such as MAIT cells. He also works on vaccine development and immune-mediated disease, with major funding from Wellcome and other international research bodies.Anna Furmanski is the Course Director of the MSc in Integrated Immunology at the University of Oxford. Trained as a T-cell immunologist, she has published widely in thymocyte development and T-cell differentiation before moving into immunology education and programme leadership. She is actively involved in teaching quality assurance and the British Society of Immunology, with a strong commitment to accessible, transformative education.